---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-003175"
form_type: "8-K"
ticker: "MGTX"
cik: "0001735438"
company_name: "MeiraGTx Holdings plc"
filed_at: "2024-03-14T23:59:59+00:00"
generated_at: "2026-06-04T19:53:56.487528+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# MeiraGTx reports FY2023 net loss of $84M, down 35% YoY; Janssen deal yields $50M milestone

## Summary
- Net loss $84.0M ($1.49/share) vs $129.6M ($2.87) in 2022; license revenue $14.0M.
- Janssen asset purchase for bota-vec (XLRP) up to $415M; $65M upfront + $50M milestone in Feb 2024.
- Sanofi invested $30M at $7.50/share; ROFN for riboswitch in CNS, I&I, metabolic disease.
- FDA aligns Phase 2 AQUAx2 for xerostomia as pivotal; AAV-AIPL1 shows meaningful responses in 8 LCA4 children.
- Cash $129.6M at Dec 31, 2023; expects funding into Q1 2026.

## SEC filing metadata
- accession: 0001558370-24-003175
- form_type: 8-K
- ticker: MGTX
- cik: 0001735438
- company_name: MeiraGTx Holdings plc
- filed_at: 2024-03-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1735438/000155837024003175/0001558370-24-003175-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1735438/000155837024003175/mgtx-20240314x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-003175
- JSON: https://secwatch.observer/filing/0001558370-24-003175.json
- Plain text: https://secwatch.observer/filing/0001558370-24-003175.txt

## Key facts
- Earnings Releases
  MeiraGTx Holdings plc reported financial results for the fourth quarter and full-year ended December 31, 2023.
  - Period: the fourth quarter and full-year ended December 31, 2023
  - Result: reported results
  source text: On March 14, 2024, MeiraGTx Holdings plc (the “Company”) issued a press release announcing its financial results for the year ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1735438/000155837024003175/0001558370-24-003175-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.